AnaptysBio (ANAB) earnings, Aug 6, 2025: EPS −116%, stock −9.6%
In brief
AnaptysBio reported on Aug 6, 2025. Earnings per share changed −116% year over year, 185.9% below the estimate; revenue −8%. The stock opened with a +4.5% gap and closed the day −9.6% (Aug 7, 2025). The stock is now 37.0% below its 52-week high, +89.9% over 12 months.
EPS vs estimate−185.9%
EPS, YoY−116%
Revenue, YoY−8%
Gap · day+4.5% · −9.6%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2025 | +4.5% | −9.6% |
Next-quarter estimates, ratings and the ANAB chart are in the terminal.
Open the terminalFAQ
When is AnaptysBio's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did AnaptysBio stock react to the report?
Opening gap +4.5%, day's result −9.6%.
Did AnaptysBio's earnings grow?
Earnings per share fell 116% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.